Literature DB >> 24408209

The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats.

Clayton T Bauer1, Matthew L Banks, S Stevens Negus.   

Abstract

RATIONALE: Chronic amphetamine treatment reduces cocaine self-administration in pre-clinical and clinical settings, and amphetamine has been proposed as a candidate medication for treatment of cocaine abuse.
OBJECTIVE: The objective of the present study was to investigate whether chronic amphetamine treatment can decrease abuse-related cocaine effects in an assay of intracranial self-stimulation (ICSS).
METHODS: Thirteen adult male Sprague-Dawley rats were equipped with intracranial electrodes targeting the medial forebrain bundle and trained to lever press for pulses of brain stimulation in a "frequency-rate" ICSS procedure. Cocaine (10 mg/kg) was administered before (day 0), during (days 7 and 14), and after (posttreatment days 1 and 3) 2 weeks of continuous treatment with either amphetamine (0.32 mg/kg/h, n = 7) or saline (n = 6) via osmotic pump.
RESULTS: Prior to treatment, cocaine facilitated ICSS in all rats. Saline treatment had no effect on baseline ICSS or cocaine-induced facilitation of ICSS at any time. Conversely, amphetamine produced a sustained though submaximal facilitation of baseline ICSS, and cocaine produced little additional facilitation of ICSS during amphetamine treatment. Termination of amphetamine treatment produced a depression of baseline ICSS and recovery of cocaine-induced facilitation of ICSS.
CONCLUSIONS: These data suggest that chronic amphetamine treatment blunts expression of abuse-related cocaine effects on ICSS in rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24408209      PMCID: PMC4040317          DOI: 10.1007/s00213-013-3405-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

Review 1.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys.

Authors:  S Stevens Negus; Nancy K Mello
Journal:  Drug Alcohol Depend       Date:  2003-05-01       Impact factor: 4.492

3.  Tolerance to amphetamine's facilitation of self-stimulation responding: anatomical specificity.

Authors:  J L Anderson; N J Leith; R J Barrett
Journal:  Brain Res       Date:  1978-04-21       Impact factor: 3.252

4.  Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.

Authors:  C T Bauer; M L Banks; B E Blough; S S Negus
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.

Authors:  Mark K Greenwald; Leslie H Lundahl; Caren L Steinmiller
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

6.  Differential effects of amphetamine and food deprivation of self-stimulation of the lateral hypothalamus and medial frontal cortex.

Authors:  R J Carey; E Goodal
Journal:  J Comp Physiol Psychol       Date:  1975-01

7.  Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats.

Authors:  Keri A Chiodo; Christopher M Läck; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

8.  Reduction of the reinforcing effectiveness of cocaine by continuous D-amphetamine treatment in rats: importance of active self-administration during treatment period.

Authors:  Benjamin A Zimmer; Keri A Chiodo; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2013-10-22       Impact factor: 4.530

9.  Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats.

Authors:  J S Bonano; R A Glennon; L J De Felice; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2013-08-15       Impact factor: 4.530

10.  Effects of d-amphetamine and naloxone on brain stimulation reward.

Authors:  R U Esposito; W Perry; C Kornetsky
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  18 in total

Review 1.  Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Authors:  S Stevens Negus; Megan J Moerke
Journal:  Peptides       Date:  2018-11-01       Impact factor: 3.750

2.  Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats.

Authors:  Amy R Johnson; Matthew L Banks; Dana E Selley; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2018-04-19       Impact factor: 7.853

3.  Effects of caffeine and its metabolite paraxanthine on intracranial self-stimulation in male rats.

Authors:  Matthew F Lazenka; F Gerard Moeller; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.157

Review 4.  Agonist Medications for the Treatment of Cocaine Use Disorder.

Authors:  S Stevens Negus; Jack Henningfield
Journal:  Neuropsychopharmacology       Date:  2014-12-11       Impact factor: 7.853

5.  Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats.

Authors:  Megan J Moerke; S Stevens Negus
Journal:  Neuropharmacology       Date:  2019-03-14       Impact factor: 5.250

6.  Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.

Authors:  J A Suyama; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

7.  Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats.

Authors:  Krista J Spiller; Guo-Hua Bi; Yi He; Ewa Galaj; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Br J Pharmacol       Date:  2019-04-03       Impact factor: 8.739

Review 8.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

9.  Opposing effects of dopamine D1- and D2-like agonists on intracranial self-stimulation in male rats.

Authors:  Matthew F Lazenka; Luke P Legakis; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2016-03-17       Impact factor: 3.157

10.  Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.

Authors:  Farhana Sakloth; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2018-03-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.